文献速递糖尿病肥胖与代谢综合征

2型糖尿病合并酒精性或非酒精性脂肪性肝病住院患者的心血管疾病、癌症与死亡率

Cardiovascular Disease, Cancer, and Mortality Among People With Type 2 Diabetes and Alcoholic or Nonalcoholic Fatty Liver Disease Hospital Admission.
PubMed 文献 · Diabetes Care · 2017-11-22

该回顾性队列研究纳入苏格兰2004至2013年40-89岁有住院记录的134,368例2型糖尿病患者,其中酒精性肝病1,707例、非酒精性脂肪性肝病1,452例。与无肝病记录组相比,两组心血管疾病、肝细胞癌、非肝细胞癌及全因死亡风险均有不同程度升高。

要点

  • 酒精性肝病和非酒精性脂肪性肝病住院记录与心血管疾病风险升高相关,校正HR分别为1.59和1.70。
  • 肝细胞癌风险显著升高,酒精性肝病校正HR为40.3,非酒精性脂肪性肝病为19.12。
  • 全因死亡风险升高,酒精性肝病校正HR为4.86,非酒精性脂肪性肝病为1.60。

核心结论

  • 在2型糖尿病患者中,酒精性肝病或非酒精性脂肪性肝病的住院记录与心血管疾病、癌症和死亡风险升高存在不同程度关联。

研究设计与样本

  • 回顾性队列研究,使用苏格兰2004至2013年糖尿病登记、医院、癌症和死亡记录的关联人群常规数据。
  • 纳入40-89岁确诊2型糖尿病且有至少一次住院记录的134,368人,其中酒精性肝病1,707例、非酒精性脂肪性肝病1,452例。
  • 肝病和结局通过ICD-9和ICD-10编码识别,采用Cox比例风险回归模型估计风险比并校正关键危险因素。
  • 心血管疾病平均随访4.3年,死亡平均随访4.7年。

主要发现

  • 酒精性肝病、非酒精性脂肪性肝病和无肝病住院记录组分别报告心血管疾病事件378例、320例和21,873例。
  • 三组分别报告癌症268例、176例和15,101例,死亡724例、221例和16,203例。
  • 与无肝病记录组相比,酒精性肝病和非酒精性脂肪性肝病的心血管疾病校正HR分别为1.59(95%CI 1.43, 1.76)和1.70(95%CI 1.52, 1.90)。
  • 肝细胞癌校正HR分别为40.3(95%CI 28.8, 56.5)和19.12(95%CI 11.71, 31.2);非肝细胞癌校正HR分别为1.28(95%CI 1.12, 1.47)和1.10(95%CI 0.94, 1.29)。
  • 全因死亡校正HR分别为4.86(95%CI 4.50, 5.24)和1.60(95%CI 1.40, 1.83)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe associations between alcoholic liver disease (ALD) or nonalcoholic fatty liver disease (NAFLD) hospital admission and cardiovascular disease (CVD), cancer, and mortality in people with type 2 diabetes mellitus (T2DM). RESEARCH DESIGN AND METHODS: We performed a retrospective cohort study by using linked population-based routine data from diabetes registry, hospital, cancer, and death records for people aged 40-89 years diagnosed with T2DM in Scotland between 2004 and 2013 who had one or more hospital admission records. Liver disease and outcomes were identified by using ICD-9 and ICD-10 codes. We estimated hazard ratios (HRs) from Cox proportional hazards regression models, adjusting for key risk factors. RESULTS: A total of 134,368 people with T2DM (1,707 with ALD and 1,452 with NAFLD) were studied, with a mean follow-up of 4.3 years for CVD and 4.7 years for mortality. Among those with ALD, NAFLD, or without liver disease hospital records 378, 320, and 21,873 CVD events; 268, 176, and 15,101 cancers; and 724, 221, and 16,203 deaths were reported, respectively. For ALD and NAFLD, respectively, adjusted HRs (95% CIs) compared with the group with no record of liver disease were 1.59 (1.43, 1.76) and 1.70 (1.52, 1.90) for CVD, 40.3 (28.8, 56.5) and 19.12 (11.71, 31.2) for hepatocellular carcinoma (HCC), 1.28 (1.12, 1.47) and 1.10 (0.94, 1.29) for non-HCC cancer, and 4.86 (4.50, 5.24) and 1.60 (1.40, 1.83) for all-cause mortality. CONCLUSIONS: Hospital records of ALD or NAFLD are associated to varying degrees with an increased risk of CVD, cancer, and mortality among people with T2DM.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Wild SH, Walker JJ, Morling JR, et al. Cardiovascular Disease, Cancer, and Mortality Among People With Type 2 Diabetes and Alcoholic or Nonalcoholic Fatty Liver Disease Hospital Admission. Diabetes Care. 2017. PMID: 29167212. doi:10.2337/dc17-1590

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。